In a multicenter clinical trial, researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.

Source: Higher doses of radiation in fewer ...or low-risk prostate cancer, study finds


David Cottle

UBB Owner & Administrator